Cargando…
Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception
To compare etonogestrel pharmacokinetic and pharmacodynamic outcomes by both self‐reported race/ethnicity and genetically determined ancestry among contraceptive implant users. We conducted a secondary analysis of our parent pharmacogenomic study of 350 implant users. We genotyped these reproductive...
Autores principales: | Lazorwitz, Aaron, Aquilante, Christina L., Shortt, Jonathan A., Sheeder, Jeanelle, Teal, Stephanie, Gignoux, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504805/ https://www.ncbi.nlm.nih.gov/pubmed/33650294 http://dx.doi.org/10.1111/cts.13014 |
Ejemplares similares
-
Letter to the Editor in Response to “Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally”
por: Lazorwitz, Aaron, et al.
Publicado: (2019) -
Using pharmacologic research to efficiently meet acute contraceptive needs
por: Lazorwitz, Aaron, et al.
Publicado: (2021) -
Herbal supplement use among reproductive-aged women in an academic infertility practice
por: Friedman, Julie, et al.
Publicado: (2022) -
The Effect of Hormonal Contraception Use on Ovarian Reserve Markers and the Uptake of Assisted Reproductive Technology in Individuals Seeking an Infertility Evaluation
por: Siegel, Dana R, et al.
Publicado: (2023) -
Integration of Catholic Values and Professional Obligations in the Provision of Family Planning Services: A Qualitative Study
por: Marchin, Angela, et al.
Publicado: (2020)